Guowei Shi

1.1k total citations
56 papers, 690 citations indexed

About

Guowei Shi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Guowei Shi has authored 56 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Urology. Recurrent topics in Guowei Shi's work include Urinary Bladder and Prostate Research (11 papers), Pelvic floor disorders treatments (10 papers) and Prostate Cancer Treatment and Research (7 papers). Guowei Shi is often cited by papers focused on Urinary Bladder and Prostate Research (11 papers), Pelvic floor disorders treatments (10 papers) and Prostate Cancer Treatment and Research (7 papers). Guowei Shi collaborates with scholars based in China, United States and Italy. Guowei Shi's co-authors include Yangyun Wang, Jifeng Wang, Yang Wang, Xilong Wang, Yongzhong Liu, Junhong Li, Bo Hu, Zhenyu Li, Zhaojuan Yang and Qian Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Guowei Shi

53 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guowei Shi China 16 442 174 150 64 64 56 690
Shicheng Yu China 16 326 0.7× 170 1.0× 107 0.7× 31 0.5× 20 0.3× 59 690
Liang Shi China 16 502 1.1× 275 1.6× 87 0.6× 15 0.2× 7 0.1× 39 828
Lifeng Ding China 15 466 1.1× 287 1.6× 80 0.5× 5 0.1× 61 1.0× 38 699
Masaomi Tajimi Japan 13 197 0.4× 19 0.1× 41 0.3× 98 1.5× 47 0.7× 34 464
Sang Bum Kim United States 16 474 1.1× 161 0.9× 93 0.6× 3 0.0× 25 0.4× 30 832
Pierre-Marie Martin France 12 146 0.3× 52 0.3× 33 0.2× 38 0.6× 9 0.1× 16 372
Minxian Qian China 14 494 1.1× 98 0.6× 47 0.3× 27 0.4× 5 0.1× 23 837
Cheng-Heng Kao Taiwan 11 517 1.2× 56 0.3× 74 0.5× 4 0.1× 22 0.3× 12 758
Tania Islam Bangladesh 13 365 0.8× 89 0.5× 90 0.6× 2 0.0× 32 0.5× 19 588
Reinhard Brunmeir Singapore 13 671 1.5× 95 0.5× 33 0.2× 6 0.1× 6 0.1× 19 857

Countries citing papers authored by Guowei Shi

Since Specialization
Citations

This map shows the geographic impact of Guowei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guowei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guowei Shi more than expected).

Fields of papers citing papers by Guowei Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guowei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guowei Shi. The network helps show where Guowei Shi may publish in the future.

Co-authorship network of co-authors of Guowei Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Guowei Shi. A scholar is included among the top collaborators of Guowei Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guowei Shi. Guowei Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Mengzhu, Yangyun Wang, Peng Wu, et al.. (2025). Efficacy and safety of non-invasive low-frequency tibial nerve stimulator in overactive bladder. European journal of medical research. 30(1). 40–40. 1 indexed citations
2.
Zhou, Cheng, et al.. (2024). USP54 is a potential therapeutic target in castration-resistant prostate cancer. BMC Urology. 24(1). 32–32. 1 indexed citations
3.
Zhou, Cheng, et al.. (2024). ANP32B inhibition suppresses the growth of prostate cancer cells by regulating c-Myc signaling. Biochemical and Biophysical Research Communications. 698. 149543–149543. 1 indexed citations
4.
Zhou, Cheng, et al.. (2023). Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer. Frontiers in Genetics. 13. 1110723–1110723. 4 indexed citations
5.
6.
7.
Xiang, Zhendong, Pan Zhang, Qiang Wu, et al.. (2021). Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide. SHILAP Revista de lepidopterología. 11(7). e495–e495. 23 indexed citations
8.
Peng, Jing, Lin Yang, Long Liu, et al.. (2021). Safety and Effectiveness of Dapoxetine On Demand in Chinese Men With Premature Ejaculation: Results of a Multicenter, Prospective, Open-Label Phase IV Study. Sexual Medicine. 9(2). 100296–100296. 5 indexed citations
9.
Wang, Yangyun, et al.. (2021). Wearing high heels with an appropriate height is protective for pelvic floor function. Translational Andrology and Urology. 10(6). 2493–2499. 1 indexed citations
10.
Li, Junhong, et al.. (2021). USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc. Journal of Experimental & Clinical Cancer Research. 40(1). 59–59. 47 indexed citations
11.
Li, Junhong, et al.. (2020). <p>Targeting eIF3f Suppresses the Growth of Prostate Cancer Cells by Inhibiting Akt Signaling</p>. OncoTargets and Therapy. Volume 13. 3739–3750. 6 indexed citations
12.
Zhang, Jun, et al.. (2020). <p>KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer</p>. OncoTargets and Therapy. Volume 13. 1303–1310. 15 indexed citations
13.
Li, Junhong, Qiang Wang, Boshi Wang, et al.. (2019). Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel. The Prostate. 79(11). 1304–1315. 20 indexed citations
14.
Wang, Yangyun, et al.. (2019). Network Pharmacology of Yougui Pill Combined with Buzhong Yiqi Decoction for the Treatment of Sexual Dysfunction. Evidence-based Complementary and Alternative Medicine. 2019. 1–10. 20 indexed citations
15.
Zhang, Jun, et al.. (2018). 1470 nm Diode Laser Enucleation vs Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia: A Randomized Study. Journal of Endourology. 33(3). 211–217. 24 indexed citations
16.
Wang, Ying, Wei Wang, Xilong Wang, et al.. (2017). Tissue-engineered sling with adipose-derived stem cells under static mechanical strain. Experimental and Therapeutic Medicine. 14(2). 1337–1342. 14 indexed citations
17.
Zhang, Jun, Xilong Wang, Yangyun Wang, et al.. (2017). Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS protein. Oncology Letters. 14(1). 363–368. 14 indexed citations
18.
Li, Zhenyu, Lejiao Jia, Jifeng Wang, et al.. (2014). Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors. European Journal of Medicinal Chemistry. 85. 359–370. 20 indexed citations
19.
Li, Zhenyu, Lejiao Jia, Jifeng Wang, et al.. (2014). Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors. European Journal of Medicinal Chemistry. 87. 346–363. 16 indexed citations
20.
Shi, Guowei, et al.. (2011). [Inhibitory effect of solanine on prostate cancer cell line PC-3 in vitro].. PubMed. 17(3). 284–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shicheng Yu Breakdown of academic impact, for papers by Liang Shi Breakdown of academic impact, for papers by Lifeng Ding Breakdown of academic impact, for papers by Masaomi Tajimi Breakdown of academic impact, for papers by Sang Bum Kim Breakdown of academic impact, for papers by Pierre-Marie Martin Breakdown of academic impact, for papers by Minxian Qian Breakdown of academic impact, for papers by Cheng-Heng Kao Breakdown of academic impact, for papers by Tania Islam Breakdown of academic impact, for papers by Reinhard Brunmeir
Rankless by CCL
2026